Trials / Unknown
UnknownNCT00051896
Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1
Double-Blind, Placebo-Controlled, Dose Escalating, Safety and Pharmacology Study With Three Dosages of GBR 12909 in Cocaine Experienced Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the potential interactions between iv cocaine and GBR 12909.
Detailed description
This is a single dose with escalation, double-blind, placebo-controlled inpatient study in which 24 cocaine experienced volunteers that meet protocol eligibility criteria during a 30 day screen period will be randomized into three dose groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GBR 12909 |
Timeline
- Start date
- 2002-08-01
- First posted
- 2003-01-20
- Last updated
- 2017-01-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00051896. Inclusion in this directory is not an endorsement.